Real-World Efficacy and Safety of Off-Label Use of Immune Checkpoint Inhibitors (ICI) in Cancer: A Retrospective Cohort Study in Qatar

被引：0
|
作者：
Abaza, S. [1 ]
Nasser, S. [1 ]
Abuyounis, M. [1 ]
Nounou, A. [1 ]
Rasul, K. [1 ]
Hamad, A. [1 ]
Elazzazy, S. [1 ]
机构：
[1] Hamad Med Corp, Natl Ctr Canc Care & Res, Doha, Qatar
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P385
引用
收藏
页码：1300 / 1301
页数：2
相关论文
共 50 条
  • [1] Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar
    Benkhadra, Maria
    Elazzazy, Shereen
    Hamad, Anas Ahmad
    Elkhatim, Mohamed S.
    Gulied, Amaal
    Sahal, Arwa Osama
    Alasmar, Aya
    Jibril, Farah I.
    Afifi, Hebatalla Mahmoud
    Nasser, Sahar
    Alnajjar, Afnan
    Dawoud, Rawan
    Omar, Nabil E.
    [J]. BLOOD, 2023, 142
  • [2] Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study
    Lushan Xiao
    Yanxia Liao
    Jiaren Wang
    Qimei Li
    Hongbo Zhu
    Chang Hong
    Ruining Li
    Jingzhe He
    Hao Cui
    Hanzhi Dong
    Lin Zeng
    Li Liu
    [J]. Cancer Immunology, Immunotherapy, 2023, 72 : 2299 - 2308
  • [3] Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study
    Xiao, Lushan
    Liao, Yanxia
    Wang, Jiaren
    Li, Qimei
    Zhu, Hongbo
    Hong, Chang
    Li, Ruining
    He, Jingzhe
    Cui, Hao
    Dong, Hanzhi
    Zeng, Lin
    Liu, Li
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2299 - 2308
  • [4] Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience
    Fontanals, Sandra
    Esteve, Anna
    Gonzalez, Andrea
    Ibanez, Cristina
    Mesia, Ricard
    Clopes, Ana
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (01):
  • [5] Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China
    Yang, Yang
    Tan, Lijie
    Hu, Jian
    Li, Yin
    Mao, Yousheng
    Tian, Ziqiang
    Zhang, Baihua
    Ma, Jianqun
    Li, Hecheng
    Chen, Chun
    Chen, Keneng
    Han, Yongtao
    Chen, Longqi
    Liu, Junfeng
    Yu, Bentong
    Yu, Zhentao
    Li, Zhigang
    [J]. DISEASES OF THE ESOPHAGUS, 2022, 35 (11)
  • [6] Real-world cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: a retrospective controlled cohort study
    Zhang, Chuan
    Chen, Zhulu
    Mo, Chunhua
    Gao, Diansha
    Zhu, Yuxi
    Qin, Shu
    Zuo, Zhong
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6074 - +
  • [7] Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
    Gong, Xiaoling
    Zhu, Yahui
    Zhang, Qianning
    Qiu, Xin
    Lu, Changchang
    Tong, Fan
    Wang, Qiaoli
    Kong, Weiwei
    Zhou, Haihui
    Liu, Baorui
    Zhou, Yujie
    Du, Juan
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [8] Efficacy and safety of immune checkpoint inhibitors in older HCC patients: A real-world study
    Cheng, J.
    Chen, B.
    Lu, Y.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S338 - S338
  • [9] The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study
    Zhang, Chenyang
    Shao, Jun
    Tang, Xiaolong
    Wu, Jiayang
    Li, Peiyi
    Li, Weimin
    Wang, Chengdi
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [10] Evaluating safety and efficacy of immune checkpoint inhibitors (ICI) in elderly patients (pts) for advanced cancer treatment: A retrospective study
    Brixius, S. J.
    Meiss, F.
    von Bubnoff, D.
    Zeiser, R.
    Waller, C. F.
    Duyster, J.
    Rawluk, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345